Patents by Inventor Anthony Peter Davis

Anthony Peter Davis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MACROCYCLIC COMPOUNDS
    Publication number: 20230365514
    Abstract: The present invention relates to macrocyclic compounds which are capable of selective binding to a target saccharide (e.g. glucose), making them particularly well suited for use in saccharide sensing applications. The present invention also relates to processes for the preparation of said compounds, to compositions and devices comprising them, and to their use in the detection of a target saccharide.
    Type: Application
    Filed: October 7, 2022
    Publication date: November 16, 2023
    Inventors: Anthony Peter Davis, Robert Tromans, Miriam Ruth Wilson, Michael Glen Orchard, Andrew Michael Chapman, Michael Roger Tomsett, Johnathan Vincent Matlock
  • Glucose sensitive insulins and uses thereof
    Patent number: 11541122
    Abstract: The present invention provides glucose sensitive insulin derivatives comprising a macrocycle, a glucose mimetic and human insulin or an analogue thereof, and their pharmaceutical use. Furthermore, the invention relates to pharmaceutical compositions comprising such glucose sensitive insulin derivatives, and to the use of such compounds for the treatment or prevention of medical conditions relating to diabetes.
    Type: Grant
    Filed: September 18, 2019
    Date of Patent: January 3, 2023
    Inventors: Thomas Hoeg-Jensen, Alice Ravn Madsen, Thomas Kruse, Per Sauerberg, Anthony Murray, Andrew Michael Chapman, Anthony Peter Davis
  • GLUCOSE SENSITIVE INSULINS AND USES THEREOF
    Publication number: 20220047708
    Abstract: The present invention provides glucose sensitive insulin derivatives comprising a macrocycle, a glucose mimetic and human insulin or an analogue thereof, and their pharmaceutical use. Furthermore, the invention relates to pharmaceutical compositions comprising such glucose sensitive insulin derivatives, and to the use of such compounds for the treatment or prevention of medical conditions relating to diabetes.
    Type: Application
    Filed: September 18, 2019
    Publication date: February 17, 2022
    Inventors: Thomas Hoeg-Jensen, Alice Ravn Madsen, Thomas Kruse, Per Sauerberg, Anthony Murray, Andrew Michael Chapman, Anthony Peter Davis